Replies to post #113075 on Biotech Values

[Jonathan Robinson]

Market having trouble digesting what this Minor Deficiency letter really is. MNTA soared and then cratered a bit (not big soaring and big cratering but some). Interesting. EDIT - found reference to similar letter from Sangstat in late 90s. Would be interesting to see if that drug got approved quickly or not.

Jon

[ThomasS]

MNTA: What a crock: "Prior to potential final product approval, the Office of Generic Drugs requires responses to a short list of questions, which Teva intends to respond to in the near future."
See my bolded text...